T. Rowe Price Investment Management, Inc. - SELECT MED HLDGS CORP ownership

SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 216 filers reported holding SELECT MED HLDGS CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of SELECT MED HLDGS CORP
ValueSharesWeighting
Q3 2023$154,610
-21.3%
6,118,306
-0.7%
0.11%
-18.7%
Q2 2023$196,389
+13.7%
6,164,109
-7.7%
0.13%
+8.1%
Q1 2023$172,697
+5.2%
6,680,734
+1.1%
0.12%
-1.6%
Q4 2022$164,123
-99.9%
6,609,861
+3.6%
0.13%
+11.5%
Q3 2022$140,976,0006,378,9720.11%
Other shareholders
SELECT MED HLDGS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
NORTH TIDE CAPITAL, LLC 13,950,000$217,620,00015.22%
RAPTOR CAPITAL MANAGEMENT LP 903,900$14,101,0007.33%
CASTLEROCK ASSET MANAGEMENT INC 155,817$2,431,0007.09%
Foyston, Gordon, & Payne Inc 899,302$14,029,0001.78%
Smith, Graham & Co., Investment Advisors, LP 625,515$9,758,0001.36%
BROADVIEW ADVISORS LLC 733,425$11,441,0001.11%
Zebra Capital Management LLC 151,353$2,361,0000.91%
DECADE CAPITAL MANAGEMENT LLC 504,820$7,875,0000.78%
Evanston Investments, Inc., dba Evanston Advisors 131,307$2,048,0000.71%
DREMAN VALUE MANAGEMENT, L L C 599,534$9,353,0000.70%
View complete list of SELECT MED HLDGS CORP shareholders